These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15850320)

  • 21. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of ophthalmic Graves' disease.
    Agapitos PJ; Hart IR
    CMAJ; 1987 Feb; 136(4):369-72. PubMed ID: 3815199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
    Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
    Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tear film profile in patients with active thyroid orbithopathy].
    Nowak M; Marek B; Kos-Kudła B; Kajdaniuk D; Siemińska L
    Klin Oczna; 2005; 107(7-9):479-82. PubMed ID: 16417002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy.
    Kurioka Y; Inaba M; Kawagishi T; Emoto M; Kumeda Y; Inoue Y; Morii H; Nishizawa Y
    Eur J Endocrinol; 2001 Feb; 144(2):99-107. PubMed ID: 11182745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum IL-1 receptor antagonist and IL-1beta in patients with Graves' opthalmopathy].
    Xie Q; Li SQ; Aa ZM; Wei SQ; Zhao HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):238-41. PubMed ID: 16608084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy.
    Le Moli R; Muscia V; Tumminia A; Frittitta L; Buscema M; Palermo F; Sciacca L; Squatrito S; Vigneri R
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):452-7. PubMed ID: 25746910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathy.
    Terwee CB; Prummel MF; Gerding MN; Kahaly GJ; Dekker FW; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):145-55. PubMed ID: 15670189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis.
    Vogel A; Elberling TV; Hørding M; Dock J; Rasmussen AK; Feldt-Rasmussen U; Perrild H; Waldemar G
    Psychoneuroendocrinology; 2007 Jan; 32(1):36-43. PubMed ID: 17097812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
    Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG
    Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial morbidity of Graves' orbitopathy.
    Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.
    Leo M; Menconi F; Rocchi R; Latrofa F; Sisti E; Profilo MA; Mazzi B; Albano E; Nardi M; Vitti P; Marcocci C; Marinò M
    Thyroid; 2015 Mar; 25(3):347-51. PubMed ID: 25584927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Observation on therapeutic effect of picking therapy on Graves' disease].
    Li GL; Zhou ZX; Li JM
    Zhongguo Zhen Jiu; 2006 Nov; 26(11):769-71. PubMed ID: 17165495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.